Correction to: NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer’s disease

Correction to: NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer’s disease

Bibliographic Details
Main Authors:	Xiao-fei He, Jing-hui Xu, Ge Li, Ming-yue Li, Li-li Li, Zhong Pei, Li-ying Zhang, Xi-quan Hu
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-05-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-022-04951-1

Similar Items

Microglial amyloid beta clearance is driven by PIEZO1 channels
by: Henna Jäntti, et al.
Published: (2022-06-01)

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease
by: Jie Pan, et al.
Published: (2025-01-01)

Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
by: Geng Lin, et al.
Published: (2020-11-01)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)

MICROGLIAL SIRT2 DEFICIENCY AGGRAVATES COGNITIVE DECLINE AND BRAIN PATHOLOGY IN ALZHEIMER’S DISEASE
by: Noemi Sola-Sevilla, et al.
Published: (2023-10-01)

Medin synergized with vascular amyloid-beta deposits accelerates cognitive decline in Alzheimer’s disease: a potential biomarker
by: Xiao Ge, et al.
Published: (2024-01-01)

PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer’s disease
by: Bian-Rong Wang, et al.
Published: (2018-05-01)

Microglial roles in Alzheimer's disease: An agent‐based model to elucidate microglial spatiotemporal response to beta‐amyloid
by: Catherine Weathered, et al.
Published: (2024-03-01)

SAMHWANG-SASIM DECOCTION ATTENUATES COGNITIVE DECLINE AND NEURONAL CELL DEATH THROUGH AMYLOID-BETA CLEARANCE AND BDNF SIGNALING IN ALZHEIMER’S DISEASE MOUSE MODELS
by: Malk Eun Pak, et al.
Published: (2023-10-01)

Optogenetic manipulation of lysosomal physiology and autophagy-dependent clearance of amyloid beta.
by: Wenping Zeng, et al.
Published: (2024-04-01)

Electroacupuncture at ST 36 ameliorates cognitive impairment and beta-amyloid pathology by inhibiting NLRP3 inflammasome activation in an Alzheimer’s disease animal model
by: Hong Ni, et al.
Published: (2023-06-01)

Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer’s disease diagnosis and therapeutic targets
by: Letian Huang, et al.
Published: (2025-12-01)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
by: QinJie Li, et al.
Published: (2022-10-01)

TXNIP/NLRP3 aggravates global cerebral ischemia-reperfusion injury-induced cognitive decline in mice
by: Chengjie Yang, et al.
Published: (2024-03-01)

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
by: Zhixin Zhang, et al.
Published: (2024-10-01)

Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in Alzheimer’s disease mouse models
by: Caroline Wasén, et al.
Published: (2024-05-01)

New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer’s Disease
by: Na Li, et al.
Published: (2022-11-01)

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
by: Shweta S. Puntambekar, et al.
Published: (2022-06-01)

Interactions between Beta-Amyloid and Pericytes in Alzheimer’s Disease
by: You-Yue Li, et al.
Published: (2024-04-01)

Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer’s disease
by: Printha Wijesinghe, et al.
Published: (2023-03-01)

Aging and Progression of Beta-Amyloid Pathology in Alzheimer’s Disease Correlates with Microglial Heme-Oxygenase-1 Overexpression
by: Cristina Fernández-Mendívil, et al.
Published: (2020-07-01)

Liver as a new target organ in Alzheimer’s disease: insight from cholesterol metabolism and its role in amyloid-beta clearance
by: Beibei Wu, et al.
Published: (2023-12-01)

Electroacupuncture Improves Clearance of Amyloid-β through the Glymphatic System in the SAMP8 Mouse Model of Alzheimer’s Disease
by: Pei-zhe Liang, et al.
Published: (2021-01-01)

Phosphorylation of AQP4 by LRRK2 R1441G impairs glymphatic clearance of IFNγ and aggravates dopaminergic neurodegeneration
by: Heng Huang, et al.
Published: (2024-01-01)

Night Photostimulation of Clearance of Beta-Amyloid from Mouse Brain: New Strategies in Preventing Alzheimer’s Disease
by: Oxana Semyachkina-Glushkovskaya, et al.
Published: (2021-11-01)

Accumulated BCAAs and BCKAs contribute to the HFD-induced deterioration of Alzheimer's disease via a dysfunctional TREM2-related reduction in microglial β-amyloid clearance
by: Yang Yang, et al.
Published: (2024-12-01)

Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease
by: Xiao-Gang Zhou, et al.
Published: (2022-08-01)

Neuroprotection of Emodin by Inhibition of Microglial NLRP3 Inflammasome-Mediated Pyroptosis
by: Wen Jiang, et al.
Published: (2023-03-01)

Monocytes release cystatin F dimer to associate with Aβ and aggravate amyloid pathology and cognitive deficits in Alzheimer’s disease
by: Qiang Li, et al.
Published: (2024-05-01)

Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
by: Li Zhong, et al.
Published: (2018-03-01)

Tyrosine phosphorylation and palmitoylation of TRPV2 ion channel tune microglial beta-amyloid peptide phagocytosis
by: Shaobin Yang, et al.
Published: (2024-09-01)

Clearance of amyloid‐beta with bispecific antibody constructs bound to erythrocytes
by: Ronald P. Taylor, et al.
Published: (2020-01-01)

Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
by: Xin Huang, et al.
Published: (2024-09-01)

Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s disease
by: Xuan Aiguo, et al.
Published: (2012-08-01)

Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease
by: Zhen Wei, et al.
Published: (2016-01-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice
by: Xiao-fei He, et al.
Published: (2017-05-01)

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
by: Lin Nan, et al.
Published: (2011-06-01)

Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease
by: Artem Zatcepin, et al.
Published: (2024-09-01)

Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity
by: An-Yi Wang, et al.
Published: (2024-08-01)